{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:25:47Z","timestamp":1776745547812,"version":"3.51.2"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jjcc.2016.04.010","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T15:59:57Z","timestamp":1467043197000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases"],"prefix":"10.1016","volume":"68","author":[{"given":"Hidemasa","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2016.04.010_bib0395","doi-asserted-by":"crossref","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0400","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(12)60075-0","article-title":"Towards regenerative therapy for cardiac disease","volume":"379","author":"Ptaszek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0405","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJMe068172","article-title":"Cardiac cell therapy \u2013 mixed results from mixed cells","volume":"355","author":"Rosenzweig","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0410","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","article-title":"Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells","volume":"59","author":"Li","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0415","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/beta-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0420","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.114.300522","article-title":"Cardiac tissue engineering: state of the art","volume":"114","author":"Hirt","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0425","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/CIRCRESAHA.116.305374","article-title":"Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications","volume":"116","author":"Sadahiro","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0430","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11739","article-title":"Functional screening identifies miRNAs inducing cardiac regeneration","volume":"492","author":"Eulalio","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0435","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","article-title":"Exosomes and cardiac repair after myocardial infarction","volume":"114","author":"Sahoo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0440","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(03)12111-3","article-title":"Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation","volume":"361","author":"Tse","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0445","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0450","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Schachinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0455","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJMoa051779","article-title":"Transcoronary transplantation of progenitor cells after myocardial infarction","volume":"355","author":"Assmus","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","article-title":"Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial","volume":"367","author":"Janssens","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0465","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","article-title":"Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months\u2019 follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial","volume":"113","author":"Meyer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0470","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0475","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0480","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.112.001035","article-title":"Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function","volume":"127","author":"Surder","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0485","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","volume":"30","author":"Tendera","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0490","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/eurheartj\/ehq449","volume":"32","author":"Hirsch","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0495","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jtcvs.2010.12.013","article-title":"Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis","volume":"142","author":"Donndorf","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0500","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.111.086074","article-title":"Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis","volume":"126","author":"Jeevanantham","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0505","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/eurjhf\/hfr148","article-title":"Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials","volume":"14","author":"Zimmet","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0510","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/eurheartj\/eht372","article-title":"Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis","volume":"35","author":"Delewi","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0515","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","article-title":"Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials","volume":"117","author":"Afzal","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0520","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","article-title":"Meta-analysis of cell therapy trials for patients with heart failure","volume":"116","author":"Fisher","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0525","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis","volume":"118","author":"Khan","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0530","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCINTERVENTIONS.113.001009","article-title":"Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials","volume":"7","author":"de Jong","year":"2014","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0535","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.116.304346","article-title":"Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data","volume":"116","author":"Gyongyosi","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0540","first-page":"g2688","article-title":"Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis","volume":"348","author":"Nowbar","year":"2014","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0545","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0550","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0555","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2014.03.022","article-title":"Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial","volume":"168","author":"Perin","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0560","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-5793(02)03477-4","article-title":"The post-natal heart contains a myocardial stem cell population","volume":"530","author":"Hierlihy","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0565","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1073\/pnas.2132126100","article-title":"Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction","volume":"100","author":"Oh","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0570","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0575","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0580","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature03215","article-title":"Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages","volume":"433","author":"Laugwitz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0585","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.115.307676","article-title":"Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies","author":"Zwetsloot","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0590","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.jacc.2008.06.052","article-title":"Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction","volume":"52","author":"Takehara","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0595","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2009.06.010","article-title":"Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine","volume":"54","author":"Leor","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0600","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.112.001075","article-title":"Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy","volume":"128","author":"Bolli","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0605","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/CIRCULATIONAHA.107.761031","article-title":"Increased cardiac myocyte progenitors in failing human hearts","volume":"118","author":"Kubo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0610","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0615","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1073\/pnas.0808920106","article-title":"c-kit expression identifies cardiovascular precursors in the neonatal heart","volume":"106","author":"Tallini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0620","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/CIRCULATIONAHA.109.909093","article-title":"Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts","volume":"121","author":"Zaruba","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0625","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","article-title":"c-kit+ cells minimally contribute cardiomyocytes to the heart","volume":"509","author":"van Berlo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0630","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1038\/ncomms9701","article-title":"Resident c-kit(+) cells in the heart are not cardiac stem cells","volume":"6","author":"Sultana","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0635","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0640","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0645","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.CIR.97.10.971","article-title":"Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy","volume":"97","author":"Patella","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0650","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0655","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0660","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","article-title":"Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction","volume":"57","author":"Lee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0665","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0670","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jacc.2013.08.724","article-title":"Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction)","volume":"63","author":"Malliaras","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0675","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2006.07.057","article-title":"Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial","volume":"48","author":"Seth","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0680","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0685","doi-asserted-by":"crossref","first-page":"e0144523","DOI":"10.1371\/journal.pone.0144523","article-title":"Widespread myocardial delivery of heart-derived stem cells by nonocclusive triple-vessel intracoronary infusion in porcine ischemic cardiomyopathy: superior attenuation of adverse remodeling documented by magnetic resonance imaging and histology","volume":"11","author":"Tseliou","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0690","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.bbrc.2006.11.096","article-title":"Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt\/GSK-3beta signaling","volume":"352","author":"Tateishi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0695","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCULATIONAHA.111.042598","article-title":"Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells","volume":"125","author":"Malliaras","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0700","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.116.304872","article-title":"Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies","volume":"116","author":"Jansen Of Lorkeers","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0705","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0710","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","article-title":"Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy","volume":"66","author":"Karantalis","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0715","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.athoracsur.2009.10.035","article-title":"Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training","volume":"89","author":"Davies","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0720","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1399-3046.2008.01024.x","article-title":"Intracoronary administration of autologous bone marrow-derived progenitor cells in a critically ill two-yr-old child with dilated cardiomyopathy","volume":"13","author":"Rupp","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0725","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.healun.2009.10.006","article-title":"A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells","volume":"29","author":"Rupp","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0730","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1017\/S1047951112000066","article-title":"Intracoronary bone marrow cell application for terminal heart failure in children","volume":"22","author":"Rupp","year":"2012","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0735","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/petr.12055","article-title":"Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy","volume":"17","author":"Bergmane","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0740","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1161\/CIRCULATIONAHA.111.084699","article-title":"A strong regenerative ability of cardiac stem cells derived from neonatal hearts","volume":"126","author":"Simpson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0745","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.116.304671","article-title":"Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial","volume":"116","author":"Ishigami","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0750","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jtcvs.2015.06.076","article-title":"Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial","volume":"150","author":"Tarui","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0755","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jtcvs.2014.10.093","article-title":"Regenerative therapy for hypoplastic left heart syndrome: first report of intraoperative intramyocardial injection of autologous umbilical-cord blood-derived cells","volume":"149","author":"Burkhart","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0760","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5966\/sctm.2014-0195","article-title":"Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system","volume":"4","author":"Cantero Peral","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0765","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCRESAHA.115.306874","article-title":"Bioengineering human myocardium on native extracellular matrix","volume":"118","author":"Guyette","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0770","doi-asserted-by":"crossref","first-page":"245ra94","DOI":"10.1126\/scitranslmed.3008681","article-title":"Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block","volume":"6","author":"Hu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0775","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature10188","article-title":"De novo cardiomyocytes from within the activated adult heart after injury","volume":"474","author":"Smart","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2016.04.010_bib0780","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature15372","article-title":"Epicardial FSTL1 reconstitution regenerates the adult mammalian heart","volume":"525","author":"Wei","year":"2015","journal-title":"Nature"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716300594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716300594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:55:48Z","timestamp":1760273748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508716300594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0914508716300594"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.04.010","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}